CLINICAL_TRIALS
trial_result
· 2011-03-22
Clinical Trial Update: A Phase 2 Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia on Hemodialysis [Phase 2]
Summary
Phase 2 study of ASP1585 in chronic kidney disease patients with hyperphosphatemia on hemodialysis completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Astellas Pharma Inc | Conditions: Hyperphosphatemia, Chronic Kidney Disease | Phase 2 | Status: COMPLETED